Cargando…
Peripheral venous catheter‐related phlebitis: A meta‐analysis of topical treatment
AIM: To systematically evaluate the efficacy of different topical treatments for PVC‐related phlebitis in hospital in‐patients. DESIGN: A systematic review and meta‐analysis. METHODS: A selection was made of experimental and quasi‐experimental studies published in English or Spanish. These should pr...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912403/ https://www.ncbi.nlm.nih.gov/pubmed/36335576 http://dx.doi.org/10.1002/nop2.1449 |
_version_ | 1784885199673229312 |
---|---|
author | Garcia‐Expósito, Judith Sánchez‐Meca, Julio Almenta‐Saavedra, José Alberto Llubes‐Arrià, Laia Torné‐Ruiz, Alba Roca, Judith |
author_facet | Garcia‐Expósito, Judith Sánchez‐Meca, Julio Almenta‐Saavedra, José Alberto Llubes‐Arrià, Laia Torné‐Ruiz, Alba Roca, Judith |
author_sort | Garcia‐Expósito, Judith |
collection | PubMed |
description | AIM: To systematically evaluate the efficacy of different topical treatments for PVC‐related phlebitis in hospital in‐patients. DESIGN: A systematic review and meta‐analysis. METHODS: A selection was made of experimental and quasi‐experimental studies published in English or Spanish. These should provide data on the degree of phlebitis, pain and infiltration (means and standard deviations, mainly) of hospitalized patients with phlebitis secondary to peripheral venous catheter. All those studies that reflected systemic or exclusive prevention treatments were excluded. Searches were from inception to April 2020. The date of data collection was from December 2020 to May 2021. The selection criteria were based on the PICOS model. Risk of bias was assessed using the Cochrane Collaboration tool. RESULTS: Twelve studies (726 patients) met the inclusion criteria. With respect to the decrease in the degree of phlebitis, was found ichthammol glycerine, followed by heparinoids. As for degree of pain, sesame oil obtained the most marked reduction. In terms of degree of infiltration, heparinoids and ichthammol glycerine were the only products to achieve a statistically significant reduction. The most important limitations are the low quantity and quality of the trials included. Insufficient data are available to draw valid conclusions about the efficacy of any treatment. |
format | Online Article Text |
id | pubmed-9912403 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99124032023-02-13 Peripheral venous catheter‐related phlebitis: A meta‐analysis of topical treatment Garcia‐Expósito, Judith Sánchez‐Meca, Julio Almenta‐Saavedra, José Alberto Llubes‐Arrià, Laia Torné‐Ruiz, Alba Roca, Judith Nurs Open Review Articles AIM: To systematically evaluate the efficacy of different topical treatments for PVC‐related phlebitis in hospital in‐patients. DESIGN: A systematic review and meta‐analysis. METHODS: A selection was made of experimental and quasi‐experimental studies published in English or Spanish. These should provide data on the degree of phlebitis, pain and infiltration (means and standard deviations, mainly) of hospitalized patients with phlebitis secondary to peripheral venous catheter. All those studies that reflected systemic or exclusive prevention treatments were excluded. Searches were from inception to April 2020. The date of data collection was from December 2020 to May 2021. The selection criteria were based on the PICOS model. Risk of bias was assessed using the Cochrane Collaboration tool. RESULTS: Twelve studies (726 patients) met the inclusion criteria. With respect to the decrease in the degree of phlebitis, was found ichthammol glycerine, followed by heparinoids. As for degree of pain, sesame oil obtained the most marked reduction. In terms of degree of infiltration, heparinoids and ichthammol glycerine were the only products to achieve a statistically significant reduction. The most important limitations are the low quantity and quality of the trials included. Insufficient data are available to draw valid conclusions about the efficacy of any treatment. John Wiley and Sons Inc. 2022-11-06 /pmc/articles/PMC9912403/ /pubmed/36335576 http://dx.doi.org/10.1002/nop2.1449 Text en © 2022 The Authors. Nursing Open published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Review Articles Garcia‐Expósito, Judith Sánchez‐Meca, Julio Almenta‐Saavedra, José Alberto Llubes‐Arrià, Laia Torné‐Ruiz, Alba Roca, Judith Peripheral venous catheter‐related phlebitis: A meta‐analysis of topical treatment |
title | Peripheral venous catheter‐related phlebitis: A meta‐analysis of topical treatment |
title_full | Peripheral venous catheter‐related phlebitis: A meta‐analysis of topical treatment |
title_fullStr | Peripheral venous catheter‐related phlebitis: A meta‐analysis of topical treatment |
title_full_unstemmed | Peripheral venous catheter‐related phlebitis: A meta‐analysis of topical treatment |
title_short | Peripheral venous catheter‐related phlebitis: A meta‐analysis of topical treatment |
title_sort | peripheral venous catheter‐related phlebitis: a meta‐analysis of topical treatment |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912403/ https://www.ncbi.nlm.nih.gov/pubmed/36335576 http://dx.doi.org/10.1002/nop2.1449 |
work_keys_str_mv | AT garciaexpositojudith peripheralvenouscatheterrelatedphlebitisametaanalysisoftopicaltreatment AT sanchezmecajulio peripheralvenouscatheterrelatedphlebitisametaanalysisoftopicaltreatment AT almentasaavedrajosealberto peripheralvenouscatheterrelatedphlebitisametaanalysisoftopicaltreatment AT llubesarrialaia peripheralvenouscatheterrelatedphlebitisametaanalysisoftopicaltreatment AT torneruizalba peripheralvenouscatheterrelatedphlebitisametaanalysisoftopicaltreatment AT rocajudith peripheralvenouscatheterrelatedphlebitisametaanalysisoftopicaltreatment |